Search research articles
Contact Us
Filters
Showing results (71-80 of 134) with videos related to
Page
of 14
Sort By:
British Journal of Cancer
|
December 1, 1989
N-benzyladriamycin-14-valerate versus progressively doxorubicin-resistant murine tumours: cellular pharmacology and characterisation of cross-resistance in vitro and in vivo
R Ganapathi, D Grabowski, T W Sweatman, et al.
British Journal of Cancer
|
January 1, 1996
Modulation of vinblastine cytotoxicity by dilantin (phenytoin) or the protein phosphatase inhibitor okadaic acid involves the potentiation of anti-mitotic effects and induction of apoptosis in human tumour cells
K I Kawamura, D Grabowski, K Weizer, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications
|
June 24, 1999
Gas chromatographic-mass spectrometric analysis of perillyl alcohol and metabolites in plasma
Z Zhang, H Chen, K K Chan, et al.
Protoplasma
|
June 21, 2022
Functional characterization of 5'-regulatory region of flavonoid 3',5'-hydroxylase-1 gene of banana plants
Sanjana Negi, Himanshu Tak, Steffi Madari, et al.
DNA and Cell Biology
|
November 1, 1991
Structural and functional analyses of the promoter of the murine multidrug resistance gene mdr3/mdr1a reveal a negative element containing the AP-1 binding site
M Ikeguchi, L D Teeter, T Eckersberg, et al.
British Journal of Cancer
|
April 1, 1986
Role of the calmodulin inhibitor trifluoperazine on the induction and expression of cell cycle traverse perturbations and cytotoxicity of daunorubicin and doxorubicin (adriamycin) in doxorubicin-resistant P388 mouse leukaemia cells
R Ganapathi, A Yen, D Grabowski, et al.
Biochemical Pharmacology
|
September 1, 1992
Overexpression of P-glycoprotein and alterations in topoisomerase II in P388 mouse leukemia cells selected in vivo for resistance to mitoxantrone
N Kamath, D Grabowski, J Ford, et al.
Biochemical Pharmacology
|
September 23, 1998
Tumor cell resistance to topoisomerase II poisons: role for intracellular free calcium in the sensitization by inhibitors or calcium-calmodulin-dependent enzymes
D R Grabowski, G R Dubyak, L Rybicki, et al.
Cancer Research
|
April 1, 1982
Tubulin as a major cell surface protein in human lymphoid cells of leukemic origin
R W Rubin, M Quillen, J J Corcoran, et al.
Biochemical Pharmacology
|
June 15, 1991
Effect of the calmodulin inhibitor trifluoperazine on phosphorylation of P-glycoprotein and topoisomerase II: relationship to modulation of subcellular distribution, DNA damage and cytotoxicity of doxorubicin in multidrug resistant L1210 mouse leukemia cells
R Ganapathi, N Kamath, A Constantinou, et al.
Page
of 14
Search research articles
Search
Showing results (71-80 of 134) with videos related to
Sort By:
Page
of 14
British Journal of Cancer
|
December 1, 1989
N-benzyladriamycin-14-valerate versus progressively doxorubicin-resistant murine tumours: cellular pharmacology and characterisation of cross-resistance in vitro and in vivo
R Ganapathi, D Grabowski, T W Sweatman, et al.
British Journal of Cancer
|
January 1, 1996
Modulation of vinblastine cytotoxicity by dilantin (phenytoin) or the protein phosphatase inhibitor okadaic acid involves the potentiation of anti-mitotic effects and induction of apoptosis in human tumour cells
K I Kawamura, D Grabowski, K Weizer, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications
|
June 24, 1999
Gas chromatographic-mass spectrometric analysis of perillyl alcohol and metabolites in plasma
Z Zhang, H Chen, K K Chan, et al.
Protoplasma
|
June 21, 2022
Functional characterization of 5'-regulatory region of flavonoid 3',5'-hydroxylase-1 gene of banana plants
Sanjana Negi, Himanshu Tak, Steffi Madari, et al.
DNA and Cell Biology
|
November 1, 1991
Structural and functional analyses of the promoter of the murine multidrug resistance gene mdr3/mdr1a reveal a negative element containing the AP-1 binding site
M Ikeguchi, L D Teeter, T Eckersberg, et al.
British Journal of Cancer
|
April 1, 1986
Role of the calmodulin inhibitor trifluoperazine on the induction and expression of cell cycle traverse perturbations and cytotoxicity of daunorubicin and doxorubicin (adriamycin) in doxorubicin-resistant P388 mouse leukaemia cells
R Ganapathi, A Yen, D Grabowski, et al.
Biochemical Pharmacology
|
September 1, 1992
Overexpression of P-glycoprotein and alterations in topoisomerase II in P388 mouse leukemia cells selected in vivo for resistance to mitoxantrone
N Kamath, D Grabowski, J Ford, et al.
Biochemical Pharmacology
|
September 23, 1998
Tumor cell resistance to topoisomerase II poisons: role for intracellular free calcium in the sensitization by inhibitors or calcium-calmodulin-dependent enzymes
D R Grabowski, G R Dubyak, L Rybicki, et al.
Cancer Research
|
April 1, 1982
Tubulin as a major cell surface protein in human lymphoid cells of leukemic origin
R W Rubin, M Quillen, J J Corcoran, et al.
Biochemical Pharmacology
|
June 15, 1991
Effect of the calmodulin inhibitor trifluoperazine on phosphorylation of P-glycoprotein and topoisomerase II: relationship to modulation of subcellular distribution, DNA damage and cytotoxicity of doxorubicin in multidrug resistant L1210 mouse leukemia cells
R Ganapathi, N Kamath, A Constantinou, et al.
Page
of 14